In addition, the CTGF promoter methylation level was 22.0±12.9% in the DN group, which was significantly lower than that in the NDM group (P<0.001) and the NDN group (P=0.019) (Fig. 3B). This evidence concerns the gene CCN2 and neonatal diabetes mellitus.